This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Furor over Aduhelm fuels debate at FDA approval
At a Providence briefing, 70 year old Alzheimer's patient Marc Archambault becomes the first non trial recipient treated with Aduhelm amid sharp criticism of the FDA approval. Critics question efficacy and cost while supporters say it may extend early disease stages.
MENTIONED IN THIS ARTICLE
Marc Archambault
Butler Hospital
Providence
R.I
Archambault
Food and Drug Administration
FDA
Medicare
Public Citizen
Steve Miller
Cigna
Janet Woodcock
Centers For Medicare and
Medicaid Services
CMS
Chiquita Brooks-LaSure
Kaiser Family Foundation